LAD1, ladinin 1, 3898

N. diseases: 87; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0202236
Disease: Triglycerides measurement
Triglycerides measurement
0.100 GeneticVariation phenotype GWASCAT Genome-wide association study identifies novel recessive genetic variants for high TGs in an Arab population. 30108155 2018
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease which is caused by a defect in fucosylation of glycoconjugates. 12476046 2002
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE These symptoms are consistent with but more severe than those reported for people with leukocyte adhesion deficiency III (LAD-III). 19234460 2009
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency-1 (LAD-1) is the result of mutations in the beta2 subunit of the CD11/CD18 integrins, LFA-1, Mac-1, p150,95 and alphadbeta2. 10936446 2000
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency 1 (LAD1) is an inherited disorder of neutrophil function. 21103413 2010
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. 20216991 2010
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency II (LAD II) is characterized by the lack of fucosylated glycoconjugates, including selectin ligands, causing immunodeficiency and severe mental and growth retardation. 11326279 2001
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Disabling mutations in integrin-mediated cell signaling have been a major focus of interest over the last decade for patients affected with leukocyte adhesion deficiency-III (LAD-III). 25854317 2015
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Kindlin-3 is a key lymphocyte function-associated antigen-1 (LFA-1) coactivator deleted in leukocyte adhesion deficiency-III (LAD-III). 21536861 2011
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Kindlin-3 is a novel integrin activator in hematopoietic cells, and its deficiency leads to immune problems and severe bleeding, known as leukocyte adhesion deficiency III (LAD-III). 22564402 2012
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE In the disorder leukocyte adhesion deficiency III (LAD-III), integrins on platelets and leukocytes are expressed but fail to function and this leads to severe bleeding and infections at an early age. 20357244 2010
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency II (LAD II) belongs to a group of human congenital diseases in which the interactions of leukocytes with the vascular endothelium are strongly impaired. 16956371 2006
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Neutrophils isolated from a child with severe leukocyte adhesion deficiency 1 (LAD1) had a complete absence of expression of the CD11/CD18 beta2 integrin family of adhesion molecules, and were shown to be deficient in the in vitro adhesion and migration properties. 10564719 2000
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency II (LAD II) is a rare congenital disease caused by defective fucosylation leading to immuno-deficiency and psychomotor retardation. 16455955 2006
Congenital leukocyte adherence deficiency
0.100 GeneticVariation disease BEFREE Leukocyte adhesion deficiency 1 (LAD-1) is caused by defects in the β2 integrin subunit. 25514840 2015
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.070 GeneticVariation group BEFREE We previously demonstrated the presence of two different populations among adult-onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA). 20546291 2010
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.070 GeneticVariation group BEFREE In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes. 25723521 2015
CUI: C0011847
Disease: Diabetes
Diabetes
0.060 GeneticVariation disease BEFREE We previously demonstrated the presence of two different populations among adult-onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA). 20546291 2010
CUI: C0011847
Disease: Diabetes
Diabetes
0.060 GeneticVariation disease BEFREE In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes. 25723521 2015
Leukocyte adhesion deficiency type 1
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type 1 (LAD 1 - CD18 deficiency) is a rare disease characterized by disturbance of phagocyte function associated with less severe cellular and humoral dysfunction. 25106692 2014
Leukocyte adhesion deficiency type 1
0.050 GeneticVariation disease BEFREE LAD I and variant LAD I syndromes are caused by mutations that impair expression or function of integrins of the beta 2 class (CD11/CD18 integrins, or "leukocyte" integrins). 11753075 2002
Leukocyte adhesion deficiency type 1
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type-1(LAD-1) is one of the immunodeficiency autosomal recessive diseases that results from mutation in integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) ITGB2 gene. 24338230 2014
Congenital disorder of glycosylation, type 2C
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type II (LAD II) is a rare genetic disease characterized by severe immunodeficiency which is related to defective expression in leukocytes of sialyl-Lewis X (SLeX), a fucosylated ligand for endothelial selectins. 9662431 1998
Congenital disorder of glycosylation, type 2C
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type II (LAD II) is caused by a disorder in the metabolism of GDP-L-fucose, which causes hypofucosylation of glycoconjugates. 10410995 1999
Congenital disorder of glycosylation, type 2C
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type II (LAD II) is a rare disorder characterized by recurrent infections, persistent leukocytosis and severe mental and growth retardation. 11529501 2001